
Previously, colorectal cancer (CRC) has been classified into four distinct molecular subtypes based on transcriptome data. These Consensus Molecular Subtypes (CMSs) have implications for our understanding of tumour heterogeneity and the prognosis of patients. So far, this classification has been based on messenger RNAs (mRNAs), although microRNAs (miRNAs) have also been shown to play a role in tumour heterogeneity and biological differences between CMSs. In contrast to mRNAs, miRNAs have a smaller size and increased stability, facilitating their detection. Therefore, the study built a miRNA‐based CMS‐classifier by converting the existing mRNA‐based CMS‐classification using machine learning (training dataset of n = 271). The performance of this miRNA‐assigned CMS‐classifier (CMS‐miRaCl) was evaluated in several datasets, achieving an overall accuracy of ~0.72 (0.6329‐0.7987) in the most extensive dataset (n = 158). To gain insight into the biological relevance of CMS‐miRaCl, we evaluated the essential features in the classifier. The study found that miRNAs previously reported to be relevant in microsatellite instable CRCs or Wnt‐signalling were essential features for CMS‐miRaCl. Following further studies to validate its robustness, this miRNA‐based alternative might simplify the implementation of CMS‐classification in clinical workflows.
Like
Save
Share